Literature DB >> 2036379

Expression of human glucose transporters in Xenopus oocytes: kinetic characterization and substrate specificities of the erythrocyte, liver, and brain isoforms.

G W Gould1, H M Thomas, T J Jess, G I Bell.   

Abstract

We describe the functional expression of three members of the family of human facilitative glucose transporters, the erythrocyte-type transporter (GLUT 1), the liver-type transporter (GLUT 2), and the brain-type transporter (GLUT 3), by microinjection of their corresponding mRNAs into Xenopus oocytes. Expression was determined by the appearance of transport activity, as measured by the transport of 3-O-methyl-D-glucose or 2-deoxy-D-glucose. We have measured the Km for 3-O-methyl-D-glucose of GLUTs 1, 2, and 3, and the results are discussed in light of the possible roles for these different transporters in the regulation of blood glucose. The substrate specificity of these transporter isoforms has also been examined. We show that, for all transporters, the transport of 2-deoxy-D-glucose is inhibited by D-but not by L-glucose. In addition, both D-galactose and D-mannose are transported by GLUTs 1-3 at significant rates; furthermore, GLUT 2 is capable of transporting D-fructose. The nature of the glucose binding sites of GLUTs 1-3 was investigated by using hexose inhibition of 2-deoxy-D-glucose uptake. We show that the characteristics of this inhibition are different for each transporter isoform.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2036379     DOI: 10.1021/bi00235a004

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  78 in total

1.  Characterization of the intracellular signalling pathways that underlie growth-factor-stimulated glucose transport in Xenopus oocytes: evidence for ras- and rho-dependent pathways of phosphatidylinositol 3-kinase activation.

Authors:  F J Thomson; T J Jess; C Moyes; R Plevin; G W Gould
Journal:  Biochem J       Date:  1997-08-01       Impact factor: 3.857

2.  Modification of glucose and glutamine metabolism in hybridoma cells through metabolic engineering.

Authors:  C Paredes; E Prats; J J Cairó; F Azorín; L Cornudella; F Gòdia
Journal:  Cytotechnology       Date:  1999-07       Impact factor: 2.058

Review 3.  The facilitative glucose transporter GLUT3: 20 years of distinction.

Authors:  Ian A Simpson; Donard Dwyer; Daniela Malide; Kelle H Moley; Alexander Travis; Susan J Vannucci
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-06-24       Impact factor: 4.310

4.  Facilitative glucose transporter 9, a unique hexose and urate transporter.

Authors:  Manuel Doblado; Kelle H Moley
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-10       Impact factor: 4.310

Review 5.  Carrier-mediated intestinal transport of drugs.

Authors:  A Tsuji; I Tamai
Journal:  Pharm Res       Date:  1996-07       Impact factor: 4.200

6.  Regulation of glucose transporters (GLUT-1 and GLUT-3) in human retinal endothelial cells.

Authors:  R M Knott; M Robertson; E Muckersie; J V Forrester
Journal:  Biochem J       Date:  1996-08-15       Impact factor: 3.857

7.  Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression.

Authors:  A De Vos; H Heimberg; E Quartier; P Huypens; L Bouwens; D Pipeleers; F Schuit
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

8.  Substrate specificity and kinetic parameters of GLUT3 in rat cerebellar granule neurons.

Authors:  F Maher; T M Davies-Hill; I A Simpson
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

9.  Lysophosphatidic acid stimulates glucose transport in Xenopus oocytes via a phosphatidylinositol 3'-kinase with distinct properties.

Authors:  F J Thomson; C Moyes; P H Scott; R Plevin; G W Gould
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

10.  Regulation of glucose transporter (GLUT 3) and aldose reductase mRNA inbovine retinal endothelial cells and retinal pericytes in high glucose and high galactose culture.

Authors:  R M Knott; M Robertson; J V Forrester
Journal:  Diabetologia       Date:  1993-09       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.